CIK 0001062822 · Non-accelerated filer<br>Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 760474169
- Phone
- 2818633000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-17 | DEBBANE RAYMOND Director | Purchase | +76,857 | $1.31 | $101K | 1,520,498 |
| 2026-02-13 | DEBBANE RAYMOND Director | Purchase | +57,952 | $1.31 | $76K | 1,443,641 |
| 2026-02-12 | McDermott Wendy SVP, Human Resources | Grant or award · Restricted Stock Units | +250,200 | 250,200 | ||
| 2026-02-12 | McDermott Wendy SVP, Human Resources | Grant or award · Stock Option (Right to Buy) | +375,300 | 375,300 | ||
| 2026-02-12 | Martens Rachel Yap SVP, Partnerships & Corp Strat | Grant or award · Restricted Stock Units | +193,740 | 193,740 | ||
| 2026-02-12 | Martens Rachel Yap SVP, Partnerships & Corp Strat | Grant or award · Stock Option (Right to Buy) | +290,620 | 290,620 | ||
| 2026-02-12 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Restricted Stock Units | +346,610 | 346,610 | ||
| 2026-02-12 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +519,920 | 519,920 | ||
| 2026-02-12 | Gopinathan Suma SVP, Discovery | Grant or award · Restricted Stock Units | +238,450 | 238,450 | ||
| 2026-02-12 | Gopinathan Suma SVP, Discovery | Grant or award · Stock Option (Right to Buy) | +357,680 | 357,680 | ||
| 2026-02-12 | DeFrancesco Lisa SVP, IR and Corp Comm | Grant or award · Restricted Stock Units | +257,530 | 257,530 | ||
| 2026-02-12 | DeFrancesco Lisa SVP, IR and Corp Comm | Grant or award · Stock Option (Right to Buy) | +386,300 | 386,300 | ||
| 2026-02-12 | Crum Brian T SVP, General Counsel & Secr. | Grant or award · Restricted Stock Units | +299,710 | 299,710 | ||
| 2026-02-12 | Crum Brian T SVP, General Counsel & Secr. | Grant or award · Stock Option (Right to Buy) | +449,560 | 449,560 | ||
| 2026-02-12 | Coiante Scott M SVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +272,680 | 272,680 | ||
| 2026-02-12 | Coiante Scott M SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +409,020 | 409,020 | ||
| 2026-02-12 | Exton Michael Chief Executive Officer | Grant or award · Restricted Stock Units | +862,440 | 862,440 | ||
| 2026-02-12 | Exton Michael Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,293,670 | 1,293,670 | ||
| 2026-02-02 | Invus Global Management, LLC Director | Grant or award | +18,553,846 | $1.30 | $24.1M | 154,734,327 |
| 2026-02-02 | Invus Global Management, LLC Director | Grant or award | +3,846,154 | $1.30 | $5.0M | 7,362,368 |
Page 5 of 15 · 285 trades